Ostara Cannabis

Ostara Cannabis concentrated 91.36% of September 2026 sales in Vapor Pens, while Edible contracted to 8.06% share; Vapor Pens were nearly flat year over year at -1.19% but fell -26.11% month over month, whereas Edible plunged -81.77% year over year and -76.23% month over month. Capsules were a small counterweight at 0.50% share with +0.03% year-over-year and +10.69% month-over-month growth, while Pre-Roll slid to 0.08% share with -78.64% year over year and -40.62% month over month. The heavy skew toward Vapor Pens alongside simultaneous double-digit month-over-month drops in both Vapor Pens (-26.11%) and Edible (-76.23%) implies a demand shock concentrated in Ostara Cannabis’s two largest lines, with only Capsules showing incremental offset, which sets up higher volatility risk given the narrow mix.

With Vapor Pens at a 91.36% mix and a rank of 15 in Missouri Vapor Pens, the brand’s positioning is effectively single-category and mid-pack, and the +13.53% year-over-year rise in average price to $29.64 against brand-level sales at -27.29% year over year suggests elasticity pressure rather than broad distribution gains. The -26.11% month-over-month slide in the core category alongside Edible’s -76.23% month over month indicates limited cross-category buffer, while Capsules’ +10.69% month over month is too small at 0.50% share to materially cushion volatility. This pattern implies that near-term stability hinges on moderating Vapor Pen price points or improving rank within the Missouri Vapor Pens set, since current mix concentration amplifies downside when the primary category underperforms.